[Lu-177]-PNT2002

Phase 3

Phase 3

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

2 competitors in Metastatic Castration-Resistant Prostate Cancer

Drug Information

Target Indication

Metastatic Castration-Resistant Prostate Cancer

Clinical Trial

Last updated: 2/10/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

LLY

Eli Lilly and Company

Related Pipeline

Diabetes Mellitus, Type 1

COVID-19

Ulcerative Colitis

Metastatic Pancreatic Cancer

Attention Deficit Hyperactivity Disorder